The invention relates to a method for preparing isoquinoline compounds and intermediate compounds obtained thereby. Such compounds can be used for preparing compounds and compositions which can reduce the activity of HIF hydroxylase enzyme, thereby improving the stability and/or activity of hypoxia inducible factors (HIF).